BioNTech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:39 AM EDT
298.20quote price arrow down-8.89 (-2.89%)
Volume
29,636
Close
307.09quote price arrow down-26.39 (-7.91%)
Volume
4,019,540
52 week range
65.72 - 464.00
Loading...
  • Open335.36
  • Day High338.50
  • Day Low305.51
  • Prev Close307.09
  • 52 Week High464.00
  • 52 Week High Date08/10/21
  • 52 Week Low65.72
  • 52 Week Low Date09/28/20

Key Stats

  • Market Cap74.475B
  • Shares Out242.52M
  • 10 Day Average Volume3.43M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change276.71

KEY STATS

  • Open335.36
  • Day High338.50
  • Day Low305.51
  • Prev Close307.09
  • 52 Week High464.00
  • 52 Week High Date08/10/21
  • 52 Week Low65.72
  • 52 Week Low Date09/28/20
  • Market Cap74.475B
  • Shares Out242.52M
  • 10 Day Average Volume3.43M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change276.71

RATIOS/PROFITABILITY

  • EPS (TTM)19.38
  • P/E (TTM)15.85
  • Fwd P/E (NTM)7.19
  • EBITDA (MRQ)6.992B
  • ROE (MRQ)133.85%
  • Revenue (MRQ)9.102B
  • Gross Margin (MRQ)85.01%
  • Net Margin (MRQ)52.41%
  • Debt To Equity (MRQ)21.87%

EVENTS

  • Earnings Date11/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
425.58-7.24-1.67%
REGN
Regeneron Pharmaceuticals Inc
619.07-19.83-3.10%
BIIB
Biogen Inc
286.62-5.09-1.74%
GRFS
Grifols SA
15.82+0.53+3.47%
MRNA
Moderna Inc
408.84-21.30-4.95%